Posterior fossa haemangioblastomas.
36 consecutive years' experience in treating 104 cases of posterior fossa haemangioblastomas is described and discussed. The mortality was 24%, with a tendency to decrease, reaching 20% in the last 15 years. About half the patients returned to neurological normality and full working capacity. Dividing the lesions into solid and cystic tumours, cystic tumours were more frequent, their survival was longer, recurrence less and postoperative state somewhat better.
Julow
J
J
St. John's Hospital, Budapest, Hungary.
Bálint
K
K
Gortvai
P
P
Pásztor
E
E
D000293:Adolescent; D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D002648:Child; D003388:Cranial Fossa, Posterior; D005260:Female; D018325:Hemangioblastoma / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate